Diagnostics and analysis of SARS-CoV-2: current status, recent
Por um escritor misterioso
Descrição
SARS-CoV-2 info - altona Diagnostics
Annual Report to the Nation Part 2 pandemic cancer diagnoses - NCI
COVID-19 test prices and payment policy - Peterson-KFF Health System Tracker
Defining the risk of SARS-CoV-2 variants on immune protection
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study - The Lancet
An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection, Cell & Bioscience
Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
COVID-19 - Wikipedia
Cover Feature: Aptamers for SARS‐CoV‐2: Isolation, Characterization, and Diagnostic and Therapeutic Developments (Anal. Sens. 5/2022) - Amini - 2022 - Analysis & Sensing - Wiley Online Library
On the Challenges for the Diagnosis of SARS-CoV-2 Based on a Review of Current Methodologies
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives - Chemical Science (RSC Publishing)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
